OneMedNet Corporation (ONMD)
NASDAQ: ONMD · Real-Time Price · USD
1.090
-0.110 (-9.17%)
At close: Apr 28, 2026, 4:00 PM EDT
1.160
+0.070 (6.42%)
Pre-market: Apr 29, 2026, 6:33 AM EDT
OneMedNet Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 1.36 | 0.64 | 1.02 | 1.15 | 1.09 | |
| Revenue Growth (YoY) | 111.35% | -37.02% | -11.43% | 5.58% | 32.49% | |
| Cost of Revenue | 1.86 | 0.92 | 1.15 | 1.51 | 1.21 | |
| Gross Profit | -0.5 | -0.28 | -0.13 | -0.36 | -0.11 | |
| Selling, General & Admin | 7.65 | 7.86 | 4.66 | 10.11 | 1.95 | |
| Research & Development | 1.52 | 1.47 | 2.07 | 0.95 | 0.64 | |
| Operating Expenses | 9.16 | 9.32 | 6.72 | 11.06 | 2.6 | |
| Operating Income | -9.67 | -9.61 | -6.85 | -11.43 | -2.71 | |
| Interest Expense | -0.07 | -0.15 | -0.01 | -0.4 | -0.2 | |
| Other Non Operating Income (Expenses) | 1.41 | -0.38 | -26.9 | 4.44 | -0.03 | |
| EBT Excluding Unusual Items | -8.33 | -10.13 | -33.76 | -7.39 | -2.94 | |
| Gain (Loss) on Sale of Investments | - | - | - | 1.37 | - | |
| Other Unusual Items | 5.53 | - | - | - | - | |
| Pretax Income | -2.8 | -10.13 | -33.76 | -6.01 | -2.94 | |
| Income Tax Expense | 0 | 0 | 0.02 | 0.21 | - | |
| Net Income | -2.8 | -10.13 | -33.78 | -6.23 | -2.94 | |
| Net Income to Common | -2.8 | -10.13 | -33.78 | -6.23 | -2.94 | |
| Shares Outstanding (Basic) | 45 | 28 | 7 | 5 | 4 | |
| Shares Outstanding (Diluted) | 45 | 28 | 7 | 5 | 4 | |
| Shares Change (YoY) | 58.67% | 286.14% | 59.46% | 5.44% | - | |
| EPS (Basic) | -0.06 | -0.36 | -4.65 | -1.37 | -0.68 | |
| EPS (Diluted) | -0.06 | -0.36 | -4.65 | -1.37 | -0.68 | |
| Free Cash Flow | -7.52 | -7 | -4.84 | 87.18 | -1.87 | |
| Free Cash Flow Per Share | -0.17 | -0.25 | -0.67 | 19.12 | -0.43 | |
| Gross Margin | -37.01% | -43.70% | -12.63% | -31.29% | -10.39% | |
| Operating Margin | -711.33% | -1493.78% | -671.20% | -991.16% | -248.27% | |
| Profit Margin | -206.11% | -1575.27% | -3308.52% | -540.42% | -269.37% | |
| Free Cash Flow Margin | -553.05% | -1089.11% | -473.56% | 7562.99% | -171.68% | |
| EBITDA | -9.6 | -9.55 | -6.83 | -11.4 | -2.7 | |
| EBITDA Margin | - | - | - | - | -246.95% | |
| D&A For EBITDA | 0.07 | 0.06 | 0.03 | 0.02 | 0.01 | |
| EBIT | -9.67 | -9.61 | -6.85 | -11.43 | -2.71 | |
| EBIT Margin | - | - | - | - | -248.27% | |
| Revenue as Reported | 1.36 | 0.64 | 1.02 | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.